CLINICAL OUTCOME MEASURES OF PSORIASIS

被引：19

作者：

Bonifati, C. ^{[1
]}

Berardesca, E. ^{[1
]}

机构：

[1] San Gallicano Dermatol Inst, Dept Clin Dermatol, Rome, Italy

来源：

REUMATISMO | 2007年 / 59卷

关键词：

Psoriasis; psoriatic arthritis; outcome;

D O I：

10.4081/reumatismo.2007.1s.64

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Several tools have been introduced in clinical trials to quantify the severity and the response to a given therapeutic regimen of both psoriasis and psoriatic arthritis. Each method present specific advantages and limitations. Here we will discuss some of the most popular clinical outcome measures of both psoriasis (Psoriasis Severity Index, Physician Global Assessment, National Psoriasis Fundation-Psoriasis Score, Dermatology Life Quality Index) and psoriatic arthritis (American College Rheumatology response criteria, Psoriatic Arthritis Response Criteria).

引用

页码：64 / 67

页数：4

共 14 条

[1] Quality of life measures in psoriasis: a critical appraisal of their quality [J].

Ashcroft, DM ;

Po, ALW ;

Williams, HC ;

Griffiths, CEM .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (05) :391-398

[2] A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis [J].

Carlin, CS ;

Feldman, SR ;

Krueger, JG ;

Menter, A ;

Krueger, GG .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (06) :859-866

[3] Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study [J].

Clegg, DO ;

Reda, DJ ;

Mejias, E ;

Cannon, GW ;

Weisman, MH ;

Taylor, T ;

BudimanMak, E ;

Blackburn, WD ;

Vasey, FB ;

Mahowald, ML ;

Cush, JJ ;

Schumacher, HR ;

Silverman, SL ;

Alepa, FP ;

Luggen, ME ;

Cohen, MR ;

Makkena, R ;

Haakenson, CM ;

Ward, RH ;

Manaster, BJ ;

Anderson, RJ ;

Ward, JR ;

Henderson, WG .

ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2013-2020

[4] Psoriasis assessment tools in clinical trials [J].

Feldman, SR ;

Krueger, GG .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :65-68

[5] AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS [J].

FELSON, DT ;

ANDERSON, JJ ;

BOERS, M ;

BOMBARDIER, C ;

FURST, D ;

GOLDSMITH, C ;

KATZ, LM ;

LIGHTFOOT, R ;

PAULUS, H ;

STRAND, V ;

TUGWELL, P ;

WEINBLATT, M ;

WILLIAMS, HJ ;

WOLFE, F ;

KIESZAK, S .

ARTHRITIS AND RHEUMATISM, 1995, 38 (06) :727-735

[6]

Felson DT, 1998, ARTHRITIS RHEUM, V41, P1564, DOI 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO

[7]

2-M

[8] DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].

FINLAY, AY ;

KHAN, GK .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216

[9] SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].

FREDRIKSSON, T ;

PETTERSSON, U .

DERMATOLOGICA, 1978, 157 (04) :238-244

[10] MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].

FRIES, JF ;

SPITZ, P ;

KRAINES, RG ;

HOLMAN, HR .

ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145

← 1 2 →